ISTO Technologies Completes Enrollment of NuQu(R) Phase 2 Trial for Back Pain
October 07, 2013 08:30 ET
|
ISTO
ST. LOUIS, Oct. 7, 2013 (GLOBE NEWSWIRE) -- ISTO Technologies, Inc. today announced that it is has completed enrollment of its Phase 2 clinical trial, to further evaluate the efficacy and safety of...
ISTO Technologies Announces Participation in OneMedForum NY 2013
June 20, 2013 08:30 ET
|
ISTO
ST. LOUIS, June 20, 2013 (GLOBE NEWSWIRE) -- ISTO Technologies, Inc. a state of the art regenerative medicine company developing innovative cartilage and bone products for spinal therapy, sports...
ISTO Technologies Assumes Full Control of DeNovo ET Cartilage Repair Technology Program
April 29, 2013 08:30 ET
|
ISTO
Collaboration Agreement With Zimmer Holdings, Inc. Ended
ISTO to Proceed Independently With Phase III Clinical Trial
ST. LOUIS, April 29, 2013 (GLOBE NEWSWIRE) -- ISTO Technologies, Inc....
ISTO Technologies Announces Participation in Canaccord Genuity Musculoskeletal Conference
March 13, 2013 08:30 ET
|
ISTO
ST. LOUIS, March 13, 2013 (GLOBE NEWSWIRE) -- ISTO Technologies, Inc., a privately-held orthobiologics company, announced today that it is participating in the 8th Annual Canaccord Genuity to be held...
ISTO Technologies Announces Participation In OneMedForum SF 2013
January 03, 2013 08:30 ET
|
ISTO
ST. LOUIS, Jan. 3, 2013 (GLOBE NEWSWIRE) -- ISTO Technologies, Inc., a privately-held orthobiologics company, announced today that it is participating in OneMedPlace's 6th Annual OneMedForum SF 2013...
ISTO Technologies, Inc. Announces Publication of Positive Results From Phase I Clinical Trial of NuQu(R) For Treatment of Low Back Pain
November 27, 2012 08:30 ET
|
ISTO
ST. LOUIS, Nov. 27, 2012 (GLOBE NEWSWIRE) -- ISTO Technologies, Inc. announced today the publication of a scientific paper in a leading peer-reviewed neurosurgery journal, the Journal of Neurosurgery:...
ISTO Technologies Awarded Spine Technology Award for NuQu(R) Technology
October 25, 2012 08:30 ET
|
ISTO
ST. LOUIS, Oct. 25, 2012 (GLOBE NEWSWIRE) -- ISTO Technologies, Inc. announced today that it has received the 2012 Spine Technology Award for its NuQu® technology. This award, which is announced...
ISTO Technologies Initiates Phase II Trial of NuQu(R): Novel Cell-Based Therapy for the Treatment of Painful Spinal Discs
October 22, 2012 08:30 ET
|
ISTO
ST. LOUIS, Oct. 22, 2012 (GLOBE NEWSWIRE) -- ISTO Technologies, Inc. announced today that it is initiating a Phase II trial to further evaluate the efficacy and safety of its NuQu® cell-based...
ISTO Technologies to Participate in the Noble Financial Capital Markets BIOX Life Sciences Exposition
September 17, 2012 08:30 ET
|
ISTO
ST. LOUIS, Mo., Sept. 17, 2012 (GLOBE NEWSWIRE) -- ISTO Technologies, Inc., a privately-held orthobiologics company, announced today that Mitchell Seyedin, Ph. D., President and Chief Executive...
ISTO Technologies Adds Veteran Healthcare Executive to Senior Management Team
July 18, 2012 08:30 ET
|
ISTO
ST. LOUIS, July 18, 2012 (GLOBE NEWSWIRE) -- ISTO Technologies Inc., a leading orthobiologics company focused on developing breakthrough products to regenerate and restore function to damaged...